title: Neuropharmacology and management of chemotherapy-induced nausea and vomiting in patients with breast cancer.
abstract: Advances in our understanding of the pathophysiology of chemotherapy-induced nausea and vomiting (CINV), the identification of patient risk factors, and the development of new antiemetics have led to significant improvements in CINV prevention. With the correct use of antiemetic drugs, CINV can be prevented in the majority of patients. Extensive clinical data have been considered in the development of antiemetic treatment recommendations by reliable institutions such as the Multinational Association of Supportive Care in Cancer, the European Society of Medical Oncology and the American Society for Clinical Oncology. These guidelines are intended to enable physicians to incorporate the latest clinical research into their daily practice, considering CINV prevention as part of an optimal patient-centered approach to cancer management. Yet despite the availability of these guidelines, there is emerging evidence that implementation of treatment recommendations is suboptimal. Recently, guideline committees gave special consideration to patient-related risk factors (young, females) contributing to the emetogenic potential for patients receiving anthracycline and cyclophosphamide-based chemotherapy. As women with breast cancer represent a particularly challenging population regarding emesis control, it is especially important that treatment recommendations are followed. This review focuses on the content of the current antiemetic guidelines, addressing the importance of how these are intended to be implemented in routine clinical practice.
authors.affiliation: Department of Hematology/Oncology, Martin Luther University Halle/Wittenberg, Germany.
authors.forename: Karin
authors.initials: K
authors.lastname: Jordan
authors.affiliation: Department of Hematology/Oncology, Martin Luther University Halle/Wittenberg, Germany.
authors.forename: Judith
authors.initials: J
authors.lastname: Schaffrath
authors.affiliation: Department of Hematology/Oncology, Martin Luther University Halle/Wittenberg, Germany.
authors.forename: Franziska
authors.initials: F
authors.lastname: Jahn
authors.affiliation: Department of Hematology/Oncology, Martin Luther University Halle/Wittenberg, Germany.
authors.forename: Carsten
authors.initials: C
authors.lastname: Mueller-Tidow
authors.affiliation: Department of Neurology, Martin Luther University Halle/Wittenberg, Germany.
authors.forename: Berit
authors.initials: B
authors.lastname: Jordan
keywords: 5-HT3 receptor antagonists; Antiemetic guidelines; Chemotherapy-induced nausea and vomiting; Neurokinin receptor antagonist